Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus

• US 20080206838A1
• Filed: 12/03/2007
• Published: 08/28/2008
• Est. Priority Date: 10/02/2001
• Status: Abandoned Application

• Current Assignee: Board of Regents of the University of Texas System (University of Texas System)
• Original Assignee: Board of Regents of the University of Texas System (University of Texas System)
• Inventors: Belcher, Angela M., Lee, Seung-Wuk
• Application Number:
  US11/987,673
• Publication Number:
  US 20080206838A1
• Time in Patent Office: Days
• US Class Current: 435/235.1
• CPC Class Codes: B82Y 10/00 Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
• CPC Class Codes: B82Y 15/00 Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
• CPC Class Codes: B82Y 30/00 Nanotechnology for materials or surface science, e.g. nanocomposites
• CPC Class Codes: B82Y 5/00 Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
• CPC Class Codes: C30B 29/58 Macromolecular compounds
• CPC Class Codes: C30B 7/00 Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions from molten solvents C30B9/00; by normal or gradient freezing C30B11/00; under a protective fluid C30B27/00
• CPC Class Codes: C30B 7/005 Epitaxial layer growth
• CPC Class Codes: G01N 33/588 with semiconductor nanocrystal label, e.g. quantum dots
• CPC Class Codes: H01L 21/02 Manufacture or treatment of semiconductor devices or of parts thereof
• CPC Class Codes: H01L 29/045 by their particular orientation of crystalline planes
• CPC Class Codes: H10K 71/191 characterised by provisions for the orientation or alignment of the layer to be deposited
• CPC Class Codes: H10K 85/761 Biomolecules or bio-macromolecules, e.g. proteins, chlorophyl, lipids or enzymes
• CPC Class Codes: Y10T 428/31504 Composite [nonstructural laminate]

Abstract

The present invention includes methods for producing nanocrystals of semiconductor material that have specific crystallographic features such as phase and alignment by using a self-assembling biological molecule that has been modified to possess an amino acid oligomer that is capable of specific binding to semi-conductor material. One form of the present invention is a method to construct ordered nanoparticles within the liquid crystal of the self-assembling biological molecule.

Claims

1-36. -36. (canceled)

37. A composition comprising (i) one or more self-assembling biological molecules or particles, and (ii) one or more synthetic peptides or proteins bound to each of the plurality of biological molecules or particles, wherein the one or more peptides or proteins contain sequences of amino acids that are selective for target crystalline surface structures with different composition or face, wherein the composition is in film form.

38. The composition according to claim 37, wherein the peptides or proteins are part of the self-assembling biological molecule or particle.

39. The composition according to claim 38, wherein the self-assembling biological molecules or particles are self-assembling proteins, and the peptides or proteins are part of the self-assembling proteins.

40. The composition according to claim 37, wherein the peptides or proteins can further nucleate and bind nanocrystals.

41. The composition according to claim 37, wherein the peptides or proteins are bound to inorganic nanocrystals of the target composition which are organized into layer domains.

42. The composition according to claim 37, wherein the peptides or proteins are bound to inorganic nanocrystals of the target composition which are organized into centimeter length scales.

43. The composition according to claim 37, wherein peptides are between about 7 to 15 amino acids in length.

44. The composition according to claim 37, wherein the peptides or proteins are part of a virus which comprises DNA which encodes binding peptide and the encoded binding peptide.

45. The composition according to claim 37, wherein the peptides or proteins are part of p3 modified bacteriophages.

46. The composition according to claim 37, wherein the peptides or proteins are part of p8 modified bacteriophages.

47. The composition according to claim 37, wherein the target crystal is a single crystal.

48. The composition according to claim 37, wherein the target crystal is part of a heterostructured crystal surface.

49. The composition according to claim 37, wherein the target crystal is an inorganic crystal.

50. The composition according to claim 37, wherein the target crystal is a semiconductor crystal.

51. The composition according to claim 37, wherein the target crystal is a nanoparticle.

52. The composition according to claim 37, wherein the target crystal is a semiconductor target crystal and comprises zinc sulfide, gallium arsenide, indium phosphate, cadmium sulfide, aluminum arsenide, aluminum stibinide, or silicon.

53. The composition according to claim 37, wherein the target crystal is CdS, FeS, ZnS, GaN, Fe₃O₄, Fe₂O₃, CdSe, ZnSe, or calcium carbonate.

54. The composition according to claim 37, wherein the target crystal is silica or calcium carbonate.

55. The composition according to claim 37, wherein the composition is in liquid crystalline film form and the binding structures are part of the self-assembling biological molecule or particle, and wherein the self-assembling biological molecule or particle is a protein and the binding structures are peptide binding structures, the composition further comprising an inorganic phase.

56. A composition comprising (i) one or more self-assembling biological molecules or particles, the self-assembling biological molecules or particles further comprising one or more synthetic peptide selective binding structures which are selective for target single crystalline surface structures with different composition or face, and (ii) an inorganic phase comprising the target composition, wherein the composition is in film form.

57. A composition comprising one or more viruses comprising synthetic peptides or proteins which are selective for target crystalline structures with different composition or face, wherein the composition is in film form and further comprises an inorganic phase.

58. A composition comprising one or more self-assembling biological molecules or particles comprising one or more peptides or proteins which are selective for target crystalline surface structures with different composition or face and which can selectively nucleate nanocrystals of the target crystal composition, wherein the composition is in film form.

59. A composition comprising one or more self-assembling biological molecules or particles, which comprise one or more synthetic peptides or proteins which can selectively nucleate nanocrystals at the binding structures, wherein the composition is in film form.

60. A composition comprising one or more liquid crystalline biological molecules or particles and one or more synthetic peptides or proteins which are selective for target crystalline surface structures with different composition or face, wherein the composition is in liquid crystalline form.

61. A composition comprising (i) one or more synthetic peptides or proteins which are selective for target crystalline surface structures with different composition or face, and (ii) an inorganic phase, wherein the composition is in dried form.

62. A method for forming a film comprising:

(i) preparing a composition comprising (a) one or more self-assembling biological molecules or particles, (b) one or more synthetic peptides or proteins which are selective for target crystalline surface structures with different composition or face,

(ii) producing a film from the composition.

64. A film composition prepared by the method according to claim 62.

63. A method for forming a film comprising:

(i) preparing a composition comprising (a) one or more self-assembling biological molecules or particles, (b) one or more synthetic peptides or proteins which are selective for target crystalline surface structures with different composition or face, (c) one or more nanoparticles,

(ii) producing a film from the composition, wherein the nanoparticles form layers in the film.